Sinopharm Group Co. Ltd. (SHTDY)
OTCMKTS
· Delayed Price · Currency is USD
11.70
+0.03 (0.22%)
Apr 30, 2025, 4:00 PM EDT
Sinopharm Group Revenue
Sinopharm Group had revenue of 141.66B CNY in the quarter ending March 31, 2025, a decrease of -5.97%. This brings the company's revenue in the last twelve months to 578.90B, down -3.24% year-over-year. In the year 2024, Sinopharm Group had annual revenue of 584.51B, down -2.02%.
Revenue (ttm)
578.90B CNY
Revenue Growth
-3.24%
P/S Ratio
0.09
Revenue / Employee
5.35M CNY
Employees
108,217
Market Cap
7.38B USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 584.51B | -12.06B | -2.02% |
Dec 31, 2023 | 596.57B | 44.42B | 8.05% |
Dec 31, 2022 | 552.15B | 31.10B | 5.97% |
Dec 31, 2021 | 521.05B | 64.64B | 14.16% |
Dec 31, 2020 | 456.41B | 31.14B | 7.32% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Sinopharm Group News
- 14 days ago - Sinopharm Group: Mixed Read-Throughs From Peer Disclosures And Management Guidance - Seeking Alpha
- 5 months ago - Sinopharm Group: The Focus Is On Working Capital And Profitability - Seeking Alpha
- 7 months ago - How AI and Sinopharm’s disruptive technologies are contributing to longer human life - The Times of India
- 4 years ago - Pandemic Accelerates China's Drive Into mRNA Treatments - Seeking Alpha
- 4 years ago - Week In Review: WHO Close To Approving Global Use For 2 China COVID-19 Vaccines - Seeking Alpha
- 4 years ago - Diversifying Into Top-Ranked Sinopharm - Seeking Alpha
- 4 years ago - Week In Review: Sinopharm Transfers $4.6 Billion In Assets Including Two COVID-19 Vaccines - Seeking Alpha
- 4 years ago - Week In Review: Eluminex Raises $50 Million For Ophthalmology Drugs - Seeking Alpha